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Abstract: 
The International HapMap Project provides a key resource of genotypic data on human lymphoblastoid cell lines derived 
from four major world populations of European, African, Chinese and Japanese ancestry for researchers to associate with 
various phenotypic data to find genes affecting health, disease and response to drugs. Recently, the HapMap resource has 
significantly benefited research areas such as gene expression variation studies. Besides some intrinsic limitations, there are 
a few challenges that should be considered in the next wave of research using this tremendous resource. We suggest that 
overcoming these challenges or considering the confounding variables in the interpretation of results can provide more 
insights into the current views of the human genome as well as complex traits such as drug response variation and 
susceptibility to common diseases. 
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Background: 
The goal of the International HapMap Project [1] is to 
develop a haplotype map of the human genome, the 
HapMap, to describe the common patterns of human DNA 
sequence variation. Four populations were selected for 
inclusion in the HapMap: 30 trios from Ibadan, Nigeria 
(YRI), 30 trios of U.S. residents of northern and western 
European ancestry (CEU), 45 unrelated individuals from 
Tokyo, Japan (JPT) and 45 unrelated Han Chinese 
individuals from Beijing, China (CHB). Epstein Barr virus 
(EBV)-transformed lymphoblastoid cell lines (LCLs) were 
derived from these individuals. The HapMap resource is 
comprised of genotypic data on ~4 million single 
nucleotide polymorphisms (SNPs), gene expression data 
using various microarray platforms, other phenotypic data 
such as drug response as well as structural variation data 
(copy number changes) [2]. In addition, there is data 
available regarding cellular sensitivity to various 
chemotherapeutic agents at PharmGKB [3]. Thus, 
investigators can utilize extensive genotype, gene 
expression and other phenotypic data on the 270 HapMap 
samples to perform various genome-wide scans for studies 
that do not require a priori knowledge or experimentation 
to generate new hypothesis. Because the HapMap samples 
provide samples from major world populations, 
investigations into inter-ethnic variation in genotype, gene 
expression and phenotype are possible. Recently, using the 
HapMap resource, some exciting progress has been made 
in the areas of gene expression variation studies and 
pharmacogenomics  [2]. Albeit the successes, there are 
some limitations of the HapMap resource [2]. For example, 
LCLs represent just one human tissue type and gene 
expression levels vary considerably among tissues. For 
pharmacologic studies, LCLs may not reflect tumor 
response or sensitivity of target tissue of known toxicity. 
Also, studies have suggested that EBV transformation may 
affect the expression of some genes and certain biological 
processes in LCLs [4, 5]. Therefore, interpretation of 
results using these cell lines may be biased by this effect. In 
this paper, we will not delve into these “intrinsic” 
limitations of the HapMap resource. Instead, we will 
discuss some of the technical challenges when utilizing the 
HapMap resource. 
 
Description: 
Problem of untyped SNPs 
The HapMap resource has allowed whole-genome 
associations to detect genetic determinants, particularly 
SNPs that affect gene expression variations (expression 
quantitative trait loci, eQTLs) and other phenotypes such as 
drug response [2]. However, a statistically significant 
association between a SNP and a phenotype does not 
necessarily indicate that the relationship is with a causal 
variant. The detected SNP could be in linkage 
disequilibrium (LD) with the casual variant. Therefore, 
involving the causal SNP or the marker SNP in LD with it 
will be critical to detect a causal association. With the 
availability of ~4 million genotypic data on SNPs, the 
HapMap resource provides a reference catalog of human 
genetic variations. The problem with the whole-genome 
associations is, however, whether the HapMap SNPs are 
sufficient to capture most of the human variation and 
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Environmental Health Sciences (NIEHS) Environmental 
Genome Project SNPs, Tantoso et al., showed that the 
HapMap SNPs are transferable to the NIEHS SNPs. 
However, the HapMap SNPs do not capture some SNPs 
(~45% for CEU and JPT/CHB, ~70% for YRI) [6]. 
Therefore, deep resequencing or a denser genotyping 
microarray would uncover more SNPs in the HapMap 
samples so that researchers can be certain that tag-SNPs 
chosen for association studies are able to comprehensively 
cover all the variants in the genes. Some efforts to 
resequence the HapMap samples include 1) the 
coordination of the HapMap Project and the ENCODE 
(ENCyclopedia Of DNA Elements) Project [7], 2) the 
SeattleSNPs Project [8] and 3) the NIEHS Environmental 
Genome Project [9]. For example, the SeattleSNPs Project 
has implemented a large-scale genotyping effort, using 
Illumina BeadArray technology, to map highly informative 
tag-SNPs from previously studied SeattleSNPs candidate 
genes in all unrelated HapMap samples. In contrast, the 
ENCODE-HapMap Coordination aims to resequence ten 
500Kb genomic regions in 48 unrelated individuals (16 
YRI, 16 CEU, 8 CHB and 8 JPT) using a PCR-based 
method. No doubt, the HapMap resource will become an 
even more powerful tool once integrated with these efforts. 
 
Confounding factors when using the resource 
Although exciting results have been generated using the 
HapMap resource [2], to date few researchers have taken 
proper care of some potential confounding factors when 
using these data. We classified these confounding factors 
into three major groups: 1) non-genetic factors such as 
batch effect, cell collection time etc. Akey et al. pointed out 
that the batch effect of a HapMap dataset could 
significantly impact the interpretation of the results of a 
gene expression variation study [10]; 2) technical 
confounding factors such as SNPs in probes. The 
confounding effect of SNPs in probes has been appreciated 
by researchers [11], however, most available HapMap gene 
expression datasets using various microarray platforms (eg. 
Affymetrix Human Focus array, Illumina BeadChip [2]) 
did not consider this effect. A recent version of expression 
dataset using the Affymetrix Human Exon array took an 
extra step to filter out probesets affected by SNPs 
maintained in dbSNP (a database of SNP data curated by 
the National Center for Biotechnology Information) when 
summarizing gene expression [2], though a more 
comprehensive comparison study may be necessary to 
investigate in detail this effect on gene expression; and 3) 
other potential confounding factors such as gender and cell 
proliferation rate need to be considered when interpreting 
results from particular association studies with expression 
and or pharmacological response. For example, some drugs 
are more effective on rapidly growing cells, therefore the 
proliferation rate may be an intermediary confounding 
effect. Genes important in cellular susceptibility to a 
particular drug could include genes that solely affect 
cellular proliferation. 
 
Conclusion: 
The HapMap resource has provided researchers a powerful 
tool to explore quantitative variation in complex traits such 
as gene expression and drug response in human populations. 
Overcoming the challenges associated with this resource or 
considering the confounding variables in the interpretation 
of results would facilitate the next wave of research using 
this tremendous resource and provide more insights into the 
current views of the human genome as well as complex 
traits such as drug response variation and susceptibility to 
common disease. 
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